COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 464.00K | 464.00K |
| Total Depreciation and Amortization | -- | -- | -- | 2.10M | 2.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -2.83M | -2.83M |
| Change in Net Operating Assets | -- | -- | -- | 2.28M | 2.28M |
| Cash from Operations | -- | -- | -- | 2.00M | 2.00M |
| Capital Expenditure | -- | -- | -- | -1.44M | -1.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 26.04M | 26.04M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -8.00K | -8.00K |
| Cash from Investing | -- | -- | -- | 24.59M | 24.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -510.00K | -510.00K |
| Issuance of Common Stock | -- | -- | -- | 13.00K | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -497.00K | -497.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -58.00K | -58.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 26.04M | 26.04M |